RNF31 and hepatocellular carcinoma: To reveal the potential downstream targets of RNF31 in HCC cells, we identified RNF31-interacting proteins in HCC cells after cells were treated with the proteasome inhibitor MG132 for 10 h by using immunoprecipitation and mass spectrometry (IP-MS).